Galmed Pharmaceuticals Has Been Granted European Patent Number EP3538158 Titled "Treatment For Fibrosis (Including Methods For Inhibition Of Fibrotic Disorders And Hepato-Fibrotic Conditions Associated With NAFLD And NASH)"
Galmed Pharmaceuticals Has Been Granted European Patent Number EP3538158 Titled "Treatment For Fibrosis (Including Methods For Inhibition Of Fibrotic Disorders And Hepato-Fibrotic Conditions Associated With NAFLD And NASH)"
Galmed Pharmicals 已獲得歐洲專利號 EP3538158，標題爲 “纖維化治療（包括抑制纖維化疾病和與 NAFLD 和 NASH 相關的肝纖維化疾病的方法）”
Galmed Pharmaceuticals Has Been Granted European Patent Number EP3538158 Titled "Treatment For Fibrosis (Including Methods For Inhibition Of Fibrotic Disorders And Hepato-Fibrotic Conditions Associated With NAFLD And NASH)"
Galmed Pharmicals 已獲得歐洲專利號 EP3538158，標題爲 “纖維化治療（包括抑制纖維化疾病和與 NAFLD 和 NASH 相關的肝纖維化疾病的方法）”
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。